Clinical Trial Update: Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 study evaluating the combination of apatinib and capecitabine to maintain treatment in metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)

Snippet

Sponsor: Yanqiao Zhang | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN